Chasing Cancer
Groundbreaking new treatments intercepting cancer at stage one. Cancer mortality rates dropping steadily across the United States. Yet a cure for cancer still seems well beyond our grasp. With evidence that up to 50% of cancers are actually preventable, renewed attention has been paid to how environmental and individual lifestyle factors may be the key to significantly reducing the risk of developing cancer.
On Oct. 17, The Washington Post hosted “Chasing Cancer,” a live event featuring nation’s most influential cancer warriors, trailblazers and advocates.
Highlights
Currently, the CDC recommends two doses of the HPV vaccine, but National Cancer Institute Acting Director Dr. Doug Lowy says researchers hope to know by 2024 whether just one dose of the vaccine will be effective in preventing cervical cancer.
  • Oct 17
Dr. Richard Pazdur, director of The Oncology Center of Excellence at the U.S. Food and Drug Administration, says that the FDA is “agnostic” when it comes to drug pricing. “We don’t make decisions based on cost…we simply look at safety and efficacy,” but concedes that how individuals pay for the drugs they need is a major issue.
  • Oct 17
Full Segment
Three influential cancer trailblazers who are on the front lines of the war against the disease discuss the most pressing issues affecting patients from innovative new treatments to drug policy to advancements in early detection and prevention.
  • Oct 17
Dr. Douglas R. Lowy
Acting Director, National Cancer Institute
Douglas R. Lowy, M.D., was officially named the National Cancer Institute’s (NCI) acting director in April 2019. He also served as acting director between April 2015 and October 2017. Prior to these appointments, Dr. Lowy has held the NCI deputy director position since July 2010, helping to lead NCI’s key scientific initiatives. Dr. Lowy received his medical degree from New York University School of Medicine and trained in internal medicine at Stanford University and dermatology at Yale University. His research interests include the biology of papillomaviruses and the regulation of normal and neoplastic cell growth. The papillomavirus research is carried out in close collaboration with Dr. John Schiller, with whom he has coauthored more than 150 papers over the past 30 years.
Ellen V. Sigal, PhD
Chairperson and Founder, Friends of Cancer Research
Ellen V. Sigal, PhD, is Chairperson and Founder of Friends of Cancer Research (Friends). Friends is an advocacy organization based in Washington, DC that drives collaboration among partners from every healthcare sector to power advances in science, policy, and regulation that speed life-saving treatments to patients. For more than two decades, Friends has been instrumental in the creation and implementation of policies ensuring patients receive the best treatments in the fastest and safest way possible. Dr. Sigal is Chair of the Board of Directors of the Reagan-Udall Foundation, a partnership designed to modernize medical product development, accelerate innovation and enhance product safety in collaboration with the U.S. Food and Drug Administration. She serves on the Board of the Foundation for the National Institutes of Health, where she chairs its Public Private Partnerships Committee.
Dr. Richard Pazdur
Director, Oncology Center of Excellence, U.S. Food and Drug Administration
Richard Pazdur, M.D. is the director of the FDA's Oncology Center of Excellence (OCE), which leverages the combined skills of the FDA's regulatory scientists and reviewers with expertise in drugs, biologics and devices to expedite the development of novel cancer products. In his role as director of the OCE, Pazdur is responsible for leading the effort to develop and execute an integrated regulatory approach to enhance the cross-center coordination of oncology product clinical review.
Moderated by Laurie McGinley
The Washington Post
Prevention is Possible
With evidence that up to 50% of cancers are actually preventable, renewed attention has been paid to how lifestyle factors such as nutrition, physical activity and early screenings may be the key to significantly reducing the risk of developing cancer. Two renowned medical experts discuss how patients can be more autonomous with their health and possibly prevent disease before it occurs.
Highlights
As colorectal cancer rates increase among young adults, experts are pointing to lifestyle choices as possible contributing factors. YouTube host ‘Dr. Mike’ Varshavski and Fred Hutchinson Cancer Research Center’s Dr. Anne McTiernan say there are some small changes, such as drinking less alcohol and getting more sleep, you can make to help decrease your risk.
  • Oct 17
YouTube host “Dr. Mike” Varshavski and Fred Hutchinson Cancer Research Center’s Dr. Anne McTiernan say the three pillars of health -- nutrition, exercise and sleep -- are integral to good health, but patients often think they can skip out on sleep.
  • Oct 17
Full Program
With evidence that up to 50% of cancers are actually preventable, renewed attention has been paid to how lifestyle factors such as nutrition, physical activity and early screenings may be the key to significantly reducing the risk of developing cancer. Two renowned medical experts discuss how patients can be more autonomous with their health and possibly prevent disease before it occurs.
  • Oct 17
Dr. Mikhail "Doctor Mike" Varshavski
Primary Care Physician/YouTube Star and Influencer
Dr. Mikhail Varshavski, commonly known as "Doctor Mike" to a massive audience of over 8 million social media subscribers, is a physician, media personality, writer, and philanthropist with a purpose. Leveraging his media presence, he educates on the importance of health literacy and battles misinformation with an entertaining and common sense approach. Between his wildly popular YouTube channel (300 million views) and recurring appearances on network TV programs like GMA, Live W/ Kelly & Ryan, Rachael Ray, and The Doctors he makes medicine relatable, enjoyable, and practical. As a family medicine specialist, Doctor Mike is uniquely equipped to cover a variety of health topics and discuss the complete patient experience as often he is the first and last point of contact for those with an extensive range of conditions.
Anne McTiernan, MD, PhD
Full Member at the Fred Hutchinson Cancer Research Center and Research Professor at the University of Washington Schools of Medicine and Public Health
Anne McTiernan, MD, PhD is a Full Member at the Fred Hutchinson Cancer Research Center, Seattle, Washington, USA, and Research Professor at the University of Washington Schools of Medicine and Public Health. Her research focuses on exercise, diet, obesity, and risk for cancer development and prognosis. She was Principal Investigator of the U.S. National Cancer Institute-funded Seattle Transdisciplinary Research on Energetics and Cancer program that investigated mechanisms linking obesity and sedentary lifestyles with cancer. She has received research funding from the U.S. National Institutes of Health, the Breast Cancer Research Foundation, Susan G. Komen, and other organizations. She is an elected Fellow in the American College of Sports Medicine and the Obesity Society.
Moderated by Paige Winfield Cunningham
The Washington Post
Imagining Hope
In 2013, Grammy Award-winning rock band Imagine Dragons co-founded the Tyler Robinson Foundation to honor the legacy of a young fan who died from a rare form of cancer. Hear the Dragons talk about the meaningful work they do with the foundation in helping children and their families deal with the many unseen emotional and financial costs of pediatric cancer.
Highlights
In 2013, Grammy Award-winning rock band Imagine Dragons co-founded the Tyler Robinson Foundation to honor the legacy of a young fan who died from a rare form of cancer. Vocalist Dan Reynolds shares how the band met Tyler and why the financial support offered by the foundation is so important. “A lot of times a parent has to drop out from work, you have to change their [the child’s] diet, it can be a lot more expensive…The average family spends, I think, $40,000.”
  • Oct 17
Imagine Dragons drummer Daniel Platzman says he wants lawmakers to know pediatric cancer ‘is not just a diagnosis for one family member.’ “This is not just an isolated, one-person diagnosis, and it’s not just something you can hit with just medical bills being paid.“
  • Oct 17
Full Program
In 2013, Grammy Award-winning rock band Imagine Dragons co-founded the Tyler Robinson Foundation to honor the legacy of a young fan who died from a rare form of cancer. Hear the Dragons talk about the meaningful work they do with the foundation in helping children and their families deal with the many unseen emotional and financial costs of pediatric cancer.
  • Oct 17
Imagine Dragons
Dan Reynolds- Lead Vocalist; Wayne Sermon- Lead Guitarist; Ben McKee-Bassist; Daniel Platzman- Drummer
Formed in 2009, Imagine Dragons first revealed their limitless passion and genre-bending sensibilities with a series of independently released EPs that quickly earned a grassroots following. After hitmaking producer Alex Da Kid signed them to Interscope Records, the band made their major-label debut with Continued Silence, a 2012 EP featuring the double-platinum breakthrough single “It's Time.” The band recently released their fourth album, ORIGINS. The album includes the #1 single "Natural," which spent nine weeks at No. 1 at alternative radio. IMAGINE DRAGONS founded The Tyler Robinson Foundation in 2013 benefitting and advocating for children who have been diagnosed with cancer and their families. The mission of the foundation is to strengthen families financially and emotionally as they cope with the tragedy of a pediatric cancer diagnosis by offsetting out-of-pocket expenses. Tyler Robinson was a superfan and friend of the Dragons who passed away from a rare form of cancer in 2013.
Moderated by Paige Winfield Cunningham
The Washington Post
Content from AstraZeneca
Precision, Prevention & Intervention
Three national advocates share their unique perspectives on oncology precision medicine, emphasizing how we can come together as a community to help ensure that the right patients receive the right treatments at the right time.
Content from AstraZeneca: Precision, Prevention & Intervention
Three national advocates share their unique perspectives on oncology precision medicine, emphasizing how we can come together as a community to help ensure that the right patients receive the right treatments at the right time.
  • Oct 17
Cynthia Bens
Senior Vice President, Public Policy at Personalized Medicine Coalition
Andrea Ferris
President and CEO at LUNGevity Foundation
Chad Ramsey
Vice President, Policy at Ovarian Cancer Research Alliance
Moderated by Adrian Kilcoyne MD, MBA, MPH
Vice President, US Medical Affairs and HEOR, AstraZeneca Oncology
About Washington Post Live
Washington Post Live is the newsroom’s live journalism platform. Top-level government and business leaders, emerging voices and newsmakers discuss the most pressing national and global issues of the day.
    Presenting Sponsor
      Supporting Sponsor